Jacob Glanville
Jacob Glanville is an Entrepreneur and Computational Immuno-Engineer. As Founder, CEO and President of Centivax, he enjoys collaborating with multiple partners to generate exciting new technologies in biomedicine.
Centivax
Universal Immunity
-
What if immunity wasn’t just personal—it was programmable, portable, and universal? This session explores the cutting edge of immunological engineering, converging rapid-response vaccine platforms, AI-designed antibody libraries, and global health deployment systems to build a world no longer vulnerable to pandemics. From biofoundry-enabled vaccine design to distributed manufacturing and last-mile delivery, the conversation will examine the technological, clinical, and infrastructural shifts needed to create scalable immune resilience—across pathogens, across borders, and across populations. Join us as we reimagine the immune system not as a biological lottery, but as an engineered global asset.